At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Sample Type (Urine Test, Saliva Test, Blood test and Others), By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others), By Region, and Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 611.01 Million

CAGR (2023-2028)

5.08%

Fastest Growing Segment

Strips/Dip Cards

Largest Market

North America


Market Overview

Global At-Home Drug of Abuse Testing Market has valued at USD 611.01 Million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.08% through 2028. Drug of Abuse testing is a clinical screening procedure used to detect one or more illegal substances such as a drug, chemical, or plant product the patient is addicted to. This clinical screening method uses the patient's urine, saliva, blood, hair, or sweat. These tests aim to identify illicit substance use or the misuse of prescription medications. At-home DOA testing provides a convenient and confidential solution for individuals who want to monitor their use, conduct screenings, or meet workplace and legal requirements. The results are often presented through simple color changes or digital readouts, ensuring easy interpretation for users.

Key Market Drivers

Prevalence of Substance Abuse

Higher rates of substance abuse lead to an increased demand for testing solutions. Individuals, families, workplaces, and even law enforcement agencies may require convenient and reliable methods to test for the presence of drugs in the body. This drives the demand for at-home drug testing kits. As substance abuse becomes more prevalent, there's often a greater emphasis on public awareness and education about its risks and consequences. This increased awareness can lead to more people seeking ways to monitor and address substance abuse, including using at-home drug testing kits to stay informed about their own or their loved ones' drug use. Parents and guardians are especially concerned about substance abuse among their children. The rise in substance abuse prevalence can prompt parents to actively seek ways to monitor their children's activities, leading to a higher demand for at-home drug testing kits that can provide a level of privacy and convenience. Many industries and employers implement drug testing as part of their employment policies, particularly in safety-sensitive roles. With higher rates of substance abuse, employers may adopt more stringent testing measures to ensure a drug-free workplace. This can boost the demand for at-home drug testing kits for pre-employment and random testing. At-home drug testing kits offer a convenient and private way for individuals to test themselves or others for drug use. As substance abuse prevalence increases, more individuals might be inclined to use these kits to monitor their own habits or to address concerns within their families, without having to visit a medical facility. Governments and regulatory bodies might respond to increasing substance abuse rates by encouraging or requiring drug testing in certain contexts. For example, probation programs, parole systems, and rehabilitation centers might incorporate regular drug testing to monitor compliance with treatment and legal requirements.

Growing Awareness

As awareness about the risks and consequences of substance abuse spreads, more individuals and families become concerned about monitoring their own or their loved ones' drug use. This leads to a higher demand for at-home drug testing kits as people seek accessible and convenient ways to address these concerns. Awareness campaigns emphasize the importance of early detection and intervention in substance abuse cases. At-home drug testing kits provide a means for individuals to take proactive measures to prevent or address substance abuse before it escalates. This preventive approach drives the adoption of these testing solutions. Parents and guardians become more attuned to the risks their children face with regard to substance abuse. Growing awareness prompts them to actively seek ways to protect their children and ensure their well-being. At-home drug testing kits offer a way for parents to monitor their children's activities and engage in conversations about substance use. People who are becoming more aware of substance abuse issues might also value privacy and confidentiality. At-home drug testing kits allow individuals to test themselves or others in the comfort of their homes without having to visit a medical facility. This level of privacy encourages more individuals to consider using these kits. As awareness increases, drug testing can become more normalized. Individuals may start viewing regular testing as a responsible behavior, similar to routine medical check-ups. This cultural shift contributes to the growth of the at-home drug testing market. Organizations, schools, and even sports associations may implement drug testing policies as a response to growing awareness about substance abuse. At-home testing kits can help individuals adhere to these policies and ensure compliance.

Rising Parental Concerns

Parents' worries about their children's potential exposure to drugs lead to a higher demand for at-home drug testing kits. They seek convenient and private ways to monitor their children's activities and ensure their safety. Parents often want to take a proactive role in preventing substance abuse among their children. At-home drug testing kits provide a tool for parents to monitor their children's behavior and have informed conversations about drug use. Parents are aware of the influence of peer pressure on their children's decisions. Concerns about their children succumbing to peer pressure and trying drugs prompt parents to consider using at-home testing kits as a preventive measure. Using at-home drug testing kits can be a way for parents to build trust with their children. By involving their children in discussions about testing and explaining their concerns, parents can foster open communication and demonstrate their commitment to their children's well-being. Parental concerns provide an opportunity for education. Parents can use at-home testing as a means to educate their children about the risks of substance abuse, the importance of making healthy choices, and the consequences of drug use. As children grow into teenagers, they seek more independence. At-home drug testing kits allow parents to empower their children to take responsibility for their decisions by discussing the importance of making drug-free choices. Parental concerns about substance abuse have evolved with changing social dynamics and the increased availability of drugs. This evolution drives the adoption of at-home drug testing kits as parents adapt to new challenges.

 

Download Free Sample Report

Key Market Challenges

Accuracy and Reliability

Inaccurate test results can lead to false positives (indicating drug use when there is none) or false negatives (not detecting drug use when it is present). These errors can have serious consequences, leading to unwarranted panic or complacency. Such errors can undermine the credibility of at-home testing kits. If at-home testing kits are perceived as inaccurate or unreliable, consumers may lose confidence in their results. This skepticism can deter individuals from purchasing or using these kits, leading to lower adoption rates. Individuals might make significant decisions based on the results of drug tests, such as seeking treatment or changing behavior. Inaccurate results could lead to misguided decisions, potentially affecting an individual's health and well-being. Inaccurate testing results can impact legal cases or employment decisions. If at-home tests yield unreliable results, individuals might face unjust consequences in legal matters or the workplace. Unsatisfactory experiences due to inaccurate or unreliable results can lead to negative reviews and word-of-mouth spread. This can tarnish the reputation of specific brands or the at-home drug testing market as a whole, hindering growth. Health regulatory agencies might impose stricter regulations on at-home drug testing kits if concerns about accuracy and reliability arise. This could increase the cost and complexity of bringing these products to market. Ensuring consistent accuracy and reliability across different batches and brands of at-home testing kits can be a challenge. Quality control issues can arise, affecting the overall perception of these products.

Limited Scope of Testing

At-home drug testing kits may not cover the full range of substances commonly abused. If the available tests only detect a limited number of drugs, individuals who are using substances not covered by the tests might not find these kits useful, reducing their appeal and adoption. The drug landscape is constantly evolving, with new substances emerging over time. At-home testing kits that do not keep up with these developments might become outdated and less relevant to users seeking to detect the latest substances. Different individuals have different testing needs based on their specific situations and concerns. If the scope of testing is limited, individuals with unique testing requirements might not find suitable options among the available at-home kits. In medical or legal contexts where a comprehensive assessment of drug use is necessary, the limited scope of at-home testing kits can be a significant drawback. Professionals might require more extensive testing, potentially leading to skepticism about the accuracy and relevance of these kits. A limited scope of testing might result in missed opportunities for early intervention and support for individuals struggling with substance abuse. More comprehensive testing could identify problematic drug use earlier and lead to timely interventions. Users might perceive limited-scope testing kits as having less value compared to more comprehensive options. This perception can impact pricing strategies and market positioning, affecting overall growth.

Key Market Trends

Advancements in Multi-Panel Testing Kits

Multi-panel testing kits can detect a variety of drugs in a single test. This comprehensive approach addresses the need for users to screen for multiple substances at once, making the kits more attractive and valuable. Users can screen for multiple drugs using a single sample, which is convenient and time-saving. This efficiency encourages more individuals to consider using at-home testing kits, thereby boosting market growth. Purchasing individual tests for each drug can be more expensive than using a multi-panel kit that tests for several drugs at once. This cost-effectiveness encourages users to opt for multi-panel kits, driving their adoption. Multi-panel testing kits cover a wider range of substances, including common drugs of abuse and emerging substances. This broader coverage meets the diverse testing needs of users, increasing the market's appeal. Parents concerned about their children's substance use are often interested in detecting multiple drugs with a single test. Multi-panel kits offer a practical solution for parents to monitor potential substance abuse. In clinical and legal settings, multi-panel testing kits provide more thorough information about an individual's drug use. This can be crucial for making informed decisions about treatment or legal matters. Public health campaigns and initiatives might emphasize comprehensive testing to address substance abuse more effectively. Multi-panel kits align with these initiatives, leading to increased adoption.

Customization and Personalization of kits

Customization allows users to choose testing kits that align with their specific needs. Individuals might have unique testing requirements based on their concerns, substances of interest, or testing frequency. Customizable options provide tailored solutions, making the testing experience more relevant and effective. Personalization takes user preferences into account, offering options like different testing methods (urine, saliva, hair), testing frequencies, and even the ability to choose the specific drugs to be tested for. Meeting these preferences can lead to higher user satisfaction and adoption. When users have the ability to personalize their testing experience, they are more likely to actively engage in the process. This engagement can lead to more consistent testing practices, supporting healthier behaviors. Personalized testing can be integrated into treatment plans for individuals recovering from substance abuse. Healthcare professionals can create testing schedules that align with the individual's needs, ensuring adherence to the plan. Parents can personalize testing based on their concerns for their children. They can choose the substances they want to test for and adjust the frequency of testing according to their child's behavior. Some individuals might be concerned about a particular type of substance or specific situations. Personalized testing allows them to focus on these concerns, enhancing the relevance of the testing process.

Segmental Insights

Product Type Insights

Based on the Product Type, the Strips/Dip Cards segment is anticipated to witness substantial market growth throughout the forecast period. This growth can be attributed to multiple factors, such as Strips and dip cards are known for their simplicity and ease of use. Users can easily perform the test by dipping the strip into a urine or saliva sample. This user-friendly design encourages broader adoption, including by individuals who might be less technologically savvy. These testing formats typically provide results within a few minutes. The quick turnaround time is appealing for users who want immediate feedback on their drug use status, making them suitable for scenarios requiring rapid testing. Compared to laboratory-based testing methods, strips and dip cards are often more affordable. Their cost-effectiveness makes at-home drug testing a viable option for a larger segment of the population. The demand for user-friendly and accessible at-home drug testing solutions has contributed to the popularity and growth of the strips and dip cards segment. Both urine and saliva-based testing using strips and dip cards are non-invasive methods, which can be preferable for users who are uncomfortable with blood-based testing.

Sample Type Insights

Based on the Sample Type segment, the Urine Test segment has been the dominant force in the market. Urine-based testing is a well-established method in the field of drug testing. It has been widely used in clinical, workplace, and legal settings, which translates to user familiarity and acceptance in the at-home testing market. Urine testing is known for its accuracy and reliability in detecting a wide range of drugs and their metabolites. This credibility enhances user trust in at-home urine-based testing kits, contributing to market growth. Collecting a urine sample is relatively simple and non-invasive, which encourages users to adopt at-home testing kits. This ease of collection contributes to the popularity of urine-based testing. Urine testing is commonly used in workplace and legal contexts to screen for drug use. This familiarity extends to the at-home testing market, where users might want to replicate the same testing method. Healthcare professionals and counselors often recommend urine-based testing due to its reliability. These recommendations can influence users to choose urine-based at-home testing kits. Urine testing is often regulated and accepted by various authorities. This regulatory acceptance facilitates the growth of the urine sample segment in the at-home testing market.

 

Download Free Sample Report

Regional Insights

North America, specifically the At-Home Drug of Abuse Testing Market, dominated the market in 2022, primarily due to North America, particularly the United States, has faced significant challenges related to substance abuse and addiction. The high prevalence of substance abuse issues in the region has driven the demand for at-home drug testing solutions. Many North American companies have stringent workplace drug testing policies to ensure a safe and productive work environment. This has boosted the demand for at-home drug testing kits, especially for pre-employment and random testing. Parents in North America are increasingly concerned about their children's exposure to drugs. The desire to monitor and protect their children from substance abuse has led to a strong demand for at-home drug testing kits. North America generally has a well-developed healthcare infrastructure and a robust market for healthcare products. This makes at-home drug testing kits readily available to consumers, facilitating their adoption. North America is often at the forefront of technological advancements. This includes the development of more accurate and user-friendly at-home drug testing kits, which attracts consumers seeking reliable solutions. The presence of multiple manufacturers and providers in North America has led to healthy market competition. This competition drives innovation, quality improvements, and a wider range of product options for consumers.

Recent Developments

  • In March 2022, the Department of Health and Human Services (HHS) offered funding of USD 58.5 million in contingency management tests for people with stimulant use disorder in California.
  • In October 2021, the manufacturer of narcotics and explosives testing kits used by law enforcement and government organizations, VeritequeUSA Inc., introduced Verifique as its first consumer brand.
  • In August 2019, Abbott entered into a partnership agreement with Intoximeters for marketing and promotion of Abbott’s SoToxaTM Mobile Test System. It is a handheld saliva testing solution that rapidly shows the results along with reliability.

Key Market Players

·         Abbott Laboratories Inc.

·         Dragerwerk AG & Co. KGaA.

·         UCP Biosciences Inc.

·         Orient New Life Medical Co. Ltd.

·         Assure Tech. (Hangzhou) Co., LTD

·         Psychemedics Corporation

·         Confirm Biosciences Inc

·         Pharmatech Inc.

·         Atlas Medical GmbH

·         Home Health (U.K.) Ltd.

By Sample Type

By Product Type

By Region
  • Urine Test
  • Saliva Test
  • Blood test
  • Others
  • Drug Testing Kits
  • Strips/Dip Cards
  • Cassettes
  • Cups
  • Others 
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global At-Home Drug of Abuse Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • At-Home Drug of Abuse Testing Market, By Sample Type:

o   Urine Test

o   Saliva Test

o   Blood test

o   Others

  • At-Home Drug of Abuse Testing Market, By Product Type:

o   Drug Testing Kit

o   Strips/Dip Cards

o   Cassettes

o   Cups

o   Others

  • At-Home Drug of Abuse Testing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global At-Home Drug of Abuse Testing Market.

Available Customizations:

Global At-Home Drug of Abuse Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global At-Home Drug of Abuse Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global At-Home Drug of Abuse Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Sample Type (Urine Test, Saliva Test, Blood test and Others)

5.2.2.    By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)

5.2.3.    By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.4.    By Company (2022)

5.3.  Market Map

               5.3.1 By Sample Type

               5.3.2 By Product Type

               5.3.3 By Region

6.    North America At-Home Drug of Abuse Testing Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Sample Type (Urine Test, Saliva Test, Blood test and Others)

6.2.2.    By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)

6.2.3.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States At-Home Drug of Abuse Testing Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.            By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.            By Sample Type

6.3.1.2.2.            By Product Type

6.3.2.    Canada At-Home Drug of Abuse Testing Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.            By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.            By Sample Type

6.3.2.2.2.            By Product Type

6.3.3.    Mexico At-Home Drug of Abuse Testing Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.            By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.            By Sample Type

6.3.3.2.2.            By Product Type

7.    Europe At-Home Drug of Abuse Testing Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Sample Type (Urine Test, Saliva Test, Blood test and Others)

7.2.2.    By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)

7.2.3.    By Country

7.3.  Europe: Country Analysis

7.3.1.    France At-Home Drug of Abuse Testing Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Sample Type

7.3.1.2.2.            By Product Type

7.3.2.    Germany At-Home Drug of Abuse Testing Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Sample Type

7.3.2.2.2.            By Product Type

7.3.3.    United Kingdom At-Home Drug of Abuse Testing Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.            By Sample Type

7.3.3.2.2.            By Product Type

7.3.4.    Italy At-Home Drug of Abuse Testing Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Sample Type

7.3.4.2.2.            By Product Type

7.3.5.    Spain At-Home Drug of Abuse Testing Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Sample Type

7.3.5.2.2.            By Product Type

8.    Asia-Pacific At-Home Drug of Abuse Testing Market Outlook

8.1.  Market Size & Forecast

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Sample Type (Urine Test, Saliva Test, Blood test and Others)

8.2.2.    By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)

8.2.3.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China At-Home Drug of Abuse Testing Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Sample Type

8.3.1.2.2.            By Product Type

8.3.2.    India At-Home Drug of Abuse Testing Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Sample Type

8.3.2.2.2.            By Product Type

8.3.3.    Japan At-Home Drug of Abuse Testing Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Sample Type

8.3.3.2.2.            By Product Type

8.3.4.    South Korea At-Home Drug of Abuse Testing Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Sample Type

8.3.4.2.2.            By Product Type

8.3.5.    Australia At-Home Drug of Abuse Testing Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Sample Type

8.3.5.2.2.            By Product Type

9.    South America At-Home Drug of Abuse Testing Market Outlook

9.1.  Market Size & Forecast

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Sample Type (Urine Test, Saliva Test, Blood test and Others)

9.2.2.    By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)

9.2.3.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil At-Home Drug of Abuse Testing Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Sample Type

9.3.1.2.2.            By Product Type

9.3.2.    Argentina At-Home Drug of Abuse Testing Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Sample Type

9.3.2.2.2.            By Product Type

9.3.3.    Colombia At-Home Drug of Abuse Testing Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Sample Type

9.3.3.2.2.            By Product Type

10.  Middle East and Africa At-Home Drug of Abuse Testing Market Outlook

10.1.   Market Size & Forecast         

10.1.1. By Value

10.2.   Market Share & Forecast

10.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)

10.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)

10.2.3. By Country

10.3.   MEA: Country Analysis

10.3.1. South Africa At-Home Drug of Abuse Testing Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Sample Type

10.3.1.2.2.         By Product Type

10.3.2. Saudi Arabia At-Home Drug of Abuse Testing Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Sample Type

10.3.2.2.2.         By Product Type

10.3.3. UAE At-Home Drug of Abuse Testing Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Sample Type

10.3.3.2.2.         By Product Type

11.  Market Dynamics

11.1.   Drivers

11.2.   Challenges

12.  Market Trends & Developments

12.1.   Recent Development

12.2.   Mergers & Acquisitions

12.3.   Product Launches

13.  Global At-Home Drug of Abuse Testing Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.   Competition in the Industry

14.2.   Potential of New Entrants

14.3.   Power of Suppliers

14.4.   Power of Customers

14.5.   Threat of Substitute Products

15.  Competitive Landscape

15.1.   Business Overview

15.2.   Product Offerings

15.3.   Recent Developments

15.4.   Financials (As Reported)

15.5.   Key Personnel

15.6.   SWOT Analysis

15.6.1    Abbott Laboratories Inc.

15.6.2    Dragerwerk AG & Co. KGaA.

15.6.3    UCP Biosciences Inc.

15.6.4    Orient New Life Medical Co. Ltd.

15.6.5    Assure Tech. (Hangzhou) Co., LTD

15.6.6    Psychemedics Corporation

15.6.7    Confirm Biosciences Inc

15.6.8    Pharmatech Inc.

15.6.9    Atlas Medical GmbH

15.6.10  Home Health (U.K.) Ltd.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global At-Home Drug of Abuse Testing Market was estimated to be USD 611.01 Million in 2022.

down-arrow

The Strips/Dip Cards segment demonstrated significant dominance in 2022, primarily driven by increasing drug overdose, research studies to understand the benefits of at-home drug test strips coupled with initiatives such as product launches by key market players.

down-arrow

North America emerged as the dominant market in 2022, capturing a significant revenue share. the high number of people who are suffering from substance abuse and initiatives by the government and rise in the use of illicit drugs in the region are also likely to fuel the market growth.

down-arrow

Reduction in the supply of illicit drugs, there was an increase in the local production of such drugs are the major drivers for the Global At-Home Drug of Abuse Testing Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

At-Home Drug of Abuse Testing Market to Grow with a CAGR of 5.08% through 2028

Oct, 2023

Growing demand for reduction in the supply of illicit drugs are expected to drive the Global At-Home Drug of Abuse Testing Market growth in the forecast period, 2024-2028.

Why Choose Us